Oral Factor Xa Inhibitors for Venous Thromboembolism Prevention in Major Orthopedic Surgery: A Review

Publisher： Karger

E-ISSN： 1424-8840|36|5|217-226

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.36, Iss.5, 2009-12, pp. : 217-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 121-128

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re‐appraisal

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S187-S194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Oral Factor Xa Inhibitors after Acute Coronary Syndrome

By  

Cardiology, Vol. 129, Iss. 4, 2014-11 ,pp. : 224-232

Karger

Access to resources Recommend Favorite

Ximelagatran, a new oral direct thrombin inhibitor, for the prevention of venous thromboembolic events in major elective orthopaedic surgery. Efficacy, safety and anaesthetic considerations

By  

ANAESTHESIA, Vol. 59, Iss. 8, 2004-08 ,pp. : 803-810

John Wiley & Sons Inc

Access to resources Recommend Favorite

The prevention of pregnancy‐related venous thromboembolism

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 2, 2015-01 ,pp. : 163-174

John Wiley & Sons Inc

Access to resources Recommend Favorite